FARMINGTON, Conn., Dec. 10, 2012 /PRNewswire-iReach/ -- Over 220 million women have an unmet need for modern contraceptives. In the developing world, while the proportion of women using modern contraceptive methods has undergone little change over the years, the number of women with an unmet need for such contraceptives has remained the same owing to various factors. The turn of the 20th century witnessed a paradigm social transformation in the developing countries from large families to smaller ones. Increased usage of modern contraception methods, and rising participation by Governmental, non-Governmental agencies, private organizations, clinics and pharmacies to increase awareness through family planning programs have all fueled growth in modern contraceptives usage. The group which faces the greatest challenge among such women are those who are poor and with low education and who live in rural and semi-urban areas having low access to services.
Furthermore, the unprecedented rate of population explosion has become a cause for grave concern the world over. One of the most devastating diseases to affect humanity is AIDS. As of 2011, about 35 million people were surviving with this life-threatening infection worldwide, while over 2.5 million newly infected cases were reported. In terms of death toll since the spread of the disease, about 30 million people have succumbed to date, with the year 2011 alone accounting for over 1.7 million deaths. AIDS is one of the leading causes of death in the world and considered the number one cause in the sub-Saharan African region.
Global Information Inc (GII) highlights two significant reports covering the global contraceptives and condoms market from our premium market research partner Global Industry Analysts, Inc.
The global market for contraceptives is forecast to exceed $20 billion by 2018. Key players profiled in the report include Ansell Limited, Bayer HealthCare Pharmaceuticals, Church & Dwight Co Inc., Conceptus Inc., Condomi Health International GmbH, Female Health Company, Fuji Latex Co., Ltd., Johnson & Johnson, Merck & Co Inc., Okamoto Industries Inc., Reckitt Benckiser Group Plc, Teva Pharmaceutical Industries Limited, and many others.
Developed markets of United States and Europe garner a substantial share of the global market for Contraceptives, as stated by the new research report. The market is driven by the growing need to avoid/postpone unwanted pregnancies, rising levels of education, sophistication, and need for pursuing career goals among young working women. About 60% of all pregnancies, particularly in developed nations such as the US are unplanned. Therefore, a keen interest in causes of unintended pregnancy and its control is one of the main criteria for Governments in the developed world. Majority of developing markets are plagued by issues of ever increasing population, alarming rise in sexually transmitted diseases and poor health and hygiene infrastructure. In the context, contraceptives with their tremendous potential to prevent undesired pregnancies and sexually transmitted diseases (STDs) hold bright growth prospects in the developing markets. Asia-Pacific, led by dynamically growing markets of India, China, Bangladesh, Pakistan and others, is set to expand at a robust CAGR of 8.6% over the analysis period.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138710-contraceptives.html
The global market for condoms is projected to reach $5.4 billion by the year 2018. Condoms are rapidly becoming a way of life for today's youth and almost as many women as men now carry condoms at all times. Over 85% of people in the 16-25 age group use condoms, which is a vast improvement on previous years when the figure was around 50%. Backed by relentless Government initiatives and international healthcare organizations, female condoms, although not as prevalent as their male counterparts, are nevertheless rapidly gaining acceptance and have completely redefined women's empowerment. A promising and innovative health technology, the female condom is set to strengthen its market presence and play an increasing role in the health protection market.
Major players in the marketplace include Ansell Limited, Condomi Health International GmbH, Church & Dwight Co. Inc., HLL Lifecare Limited, Karex Industries Sdn Bhd., The Female Health Company, Fuji Latex Co., Ltd., Okamoto Industries, and Reckitt Benckiser Group Plc.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go134262-condoms.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.